Literature DB >> 12405155

Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin.

Asta Juzeniene1, Petras Juzenas, Olav Kaalhus, Vladimir Iani, Johan Moan.   

Abstract

Significant amounts of protoporphyrin IX (PpIX) are formed after 6 min of topical application of 5-aminolevulinic acid (ALA) and its hexylester derivative, whereas PpIX is formed after 10 min of topical application of ALA-methylester derivative in normal mouse skin at 37 degrees C. Lowering the skin temperature to 28-32 degrees C by the administration of the anesthetic Hypnorm-Dormicum reduces the PpIX fluorescence by a factor of 2-3. Practically no PpIX was formed as long as the skin temperature was kept at 12-18 degrees C. At around 30 degrees C PpIX fluorescence appears later after application of ALA-ester derivatives (14-20 min) than after application of ALA (8 min), indicating differences in their bioavailability (delayed penetration through the stratum corneum, cellular uptake, conversion to ALA, PpIX production) in mouse skin in vivo. The difference in lag time in the PpIX formation after application of ALA and ALA-esters may be partly related to deesterification of the ALA-ester molecules. The temperature dependence of PpIX production may be used for improvement of photodynamic therapy with ALA and ALA-ester derivatives, where accumulation of PpIX can be selectively enhanced by increasing the temperature of the target tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405155     DOI: 10.1562/0031-8655(2002)076<0452:teoaop>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  3 in total

1.  Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy.

Authors:  Asta Juzeniene; Petras Juzenas; Li-Wei Ma; Vladimir Iani; Johan Moan
Journal:  Lasers Med Sci       Date:  2004-10-16       Impact factor: 3.161

2.  Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.

Authors:  S C Kanick; S C Davis; Y Zhao; K L Sheehan; T Hasan; E V Maytin; B W Pogue; M S Chapman
Journal:  Photodiagnosis Photodyn Ther       Date:  2015-10-22       Impact factor: 3.631

3.  An In Vitro Approach to Photodynamic Therapy.

Authors:  Evan Austin; Jared Jagdeo
Journal:  J Vis Exp       Date:  2018-08-17       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.